Translocating peptides and proteins and their use for gene delivery

Current Opinion in Biotechnology

Volumn 11, Issue 5, 2000, Pages 461-466

  Morris, May C ^a   Chaloin, Laurent ^b   Heitz, Frederic ^b   Divita, Gilles ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN;

BIOTECHNOLOGY; ENDOSOME; GENE TARGETING; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; REVIEW;

EID: 0033776303     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00128-2     Document Type: Review

References (57)

1. Human gene therapy
2. Nonviral gene therapy: The promise of genes as pharmaceutical products
3. Synthetic DNA delivery systems
4. Pharmaceutical perspectives of nonviral gene therapy
5. Lipidic vector systems for gene transfer
6. Application of lipids and plasmid design for gene delivery to mammalian cells
7. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimime
8. Peptide-based gene delivery
9. DNA condensation by multivalent cations
10. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system
11. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes
12. A powerful nonviral vector for in vitro gene transfer into the adult mammalian brain: Polyethyleneimine
13. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells
14. DNA complexes with polycations for the delivery of genetic material into cells
15. Branched cationic peptides for gene delivery: Role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes
16. Synthetic peptide-based DNA complexes for non viral gene delivery
17. Monomolecular collapse of plasmid DNA into stable virus-like particles
18. Peptide mediated gene delivery influence of peptide structure on gene expression
19. A potent new class of reductively activated peptide gene delivery agents
20. An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery
21. αω integrins as receptors for tumor targeting by circulating ligands
22. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells
23. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand
24. Receptor-mediated gene transfer into macrophages
25. Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice
26. Effects of membrane-active agents in gene delivery
27. Application of membrane-active peptides for drug and gene delivery across cellular membrane
28. Membrane binding conformational properties of peptides representing the NH2 terminus of influenza HA-2
29. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer system
30. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene transfer vehicle
31. Association of a pH-sensitive peptide with membrane vesicles: Role of amino-acid sequence
32. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer
33. Polyamidoamine cascade polymers mediate efficient transfection of the cell in culture
34. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines
35. A new peptide vector for efficient delivery of oligonucleotide into nontransformed mammalian cells
36. A novel potent strategy for gene delivery Using a single peptide vector as a carrier
37. Nucleocytoplasmic transport
38. Nucleocytoplasmic transport: The soluble phase
39. Synthetic peptides as nuclear localization signals
40. Conformations of primary amphipathic carrier peptides in membrane mimicking environments
41. DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNA
42. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
43. Coupling of nuclear localization signales to plasmid DNA and specific interaction of the conjugates with importin α
44. Efficacy of a peptide-based gene delivery system depends on mitotic activity
45. Cyclic amphipathic peptide-DNA complexes mediate high efficiency transfection of adherent mammalian cells
46. Design, synthesis and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers
47. Binding of cationic α-helical peptides to plasmid DNA and their gene transfer abilities into cells
48. Chain length of cationic α-helical peptide sufficient for gene delivery into cells
49. Efficient gene transfer by histidylated polylysine/pDNA complexes
50. Efficient gene delivery by a peptide derived from monoclonal anti-DNA antibody
51. Muiticomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice
52. Novel vectors for gene delivery formed by self assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers
53. Mutual exclusivity of DNA binding and nuclear localization signal recognition by the yeast transcription factor GAL4: Implications for non-viral DNA delivery
54. Hepatocyte-targeted in vivo gene expression by intravenous injection of piasmid DNA complexed with synthetic multi-functional gene delivery system
55. Interaction of primary amphipatic vector peptides with membranes: Conformational consequences and influence on cellular localisation
56. Emulsion formulations as a vector for gene delivery in vitro and in vivo
57. Decreased binding and cells of proteins and cells of polymeric gene delivery vector surface modified with a multivalent hydrophilic polymer and targeting through attachment of tranferrin